Hepion Pharmaceuticals, Inc. (HEPA)
HEPA is quoted over the counter, not listed on an exchange. Hepion Pharmaceuticals, Inc. files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.
Closes: Yahoo Finance daily closes, last bar 2026-11-16.
Profile
| Field | Value |
|---|---|
| Ticker | HEPA, quoted over the counter |
| SEC CIK | 0001583771 |
| OTC Markets tier | OTCQB (price source, 2026-11-13) |
| SEC industry code | Pharmaceutical Preparations |
| Business address | Red Bank, NJ |
| Incorporated in | DE |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | States substantial doubt about continuing as a going concern. "Due to our recurring and expected continuing losses from operations, we have concluded there is substantial doubt in our ability to continue as a going concern within one year of the issuance of these condensed consolidated financial statements without additional capital becoming available to us." | 10-Q 2026-08-13 |
| Cash and burn | $1.6M cash; operating cash flow -$399K a quarter. | Report 2026-06-30 |
| Shares outstanding | 90,219,317 (2026-08-10); 11,620,317 a year earlier; 3,838,289 three years earlier. 3y figure adjusted for splits (1-for-50 overall). | Cover page 2026-08-10 |
| Reverse splits, 3 years | 1; latest 1-for-50 on 2025-03-18 | Source 2025-03-18 |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Delisting | 25-NSE filed | 25-NSE 2025-07-22 |
| Auditor | Grassi & Co., CPAs, P.C., Jericho, New York, United States; changed auditors 1 time in 24 months | 8-K 4.01 2026-09-28 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $175K, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q2 2026 2026-06-30 | Not filed | -$1.2M | -$1.4M | $1.6M | $0 | Needs four quarters | 10-Q 2026-08-13 |
| Q1 2026 2026-03-31 | Not filed | -$811K | $579K | $2.6M | $0 | Needs four quarters | 10-Q 2026-08-13 |
| Q4 2025 2025-12-31 | Not filed | -$657K | -$333K | $1.8M | $54K | Needs four quarters | 10-K 2026-03-12 |
| Q3 2025 2025-09-30 | Not filed | -$473K | -$446K | $2.3M | $214K | Needs four quarters | 10-Q 2025-11-12 |
| Q2 2025 2025-06-30 | Not filed | -$1.0M | -$1.4M | $2.9M | $372K | Needs four quarters | 10-Q 2026-08-13 |
| Q1 2025 2025-03-31 | Not filed | -$6.1M | -$1.1M | $4.6M | $526K | Needs four quarters | 10-Q 2026-08-13 |
| Q4 2024 2024-12-31 | Not filed | -$1.5M | -$1.2M | $406K | $2.9M | Needs four quarters | 10-K 2026-03-12 |
| Q3 2024 2024-09-30 | Not filed | -$4.9M | -$2.5M | $1.5M | $2.1M | Needs four quarters | 10-Q 2025-11-12 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B4 | 2025-01-23 |
| Latest annual report | 10-K | 2026-03-12 |
| Latest quarterly / interim | 10-Q | 2026-11-16 |
| Latest current report | 8-K | 2026-10-09 |
| Latest proxy | DEFA14A | 2026-04-28 |
Source: SEC EDGAR submissions feed, 724 recent filings. All filings on EDGAR.
The full dossier has every filing, quarterly and annual financials, the health record and a price chart.
Open the full dossier